Multimodality Monitoring Consensus Statement: Monitoring in Emerging Economies

摘要: The burden of disease and so the need for care is often greater at hospitals in emerging economies. This compounded by frequent restrictions delivery good quality clinical due to resource limitations. However, there substantial heterogeneity this economically defined group, such that advanced brain monitoring routinely practiced certain centers have an interest neurocritical care. It also must be recognized significant exists even within individual high-income countries (HICs), determined costs level interest. Direct comparisons data between HICs group low- middle-income (LAMICs) are made difficult differences patient demographics, selection ICU admission, therapies administered, outcome assessment. Evidence suggests potential benefits multimodality depend on appropriate environment expertise. There no evidence suggest patients LAMICs where resources exist should treated any differently from HICs. arguably absolute terms because large disease; however, relative cost/benefit ratio setting viewed context overall priorities delivering health institutions.